en
/
sv
About Elicera
Elicera in brief
Board
Management
Elicera's history
Immuno-oncology
What is immuno-oncology?
Oncolytic virus
CAR T-cell therapy
Technology
Strengths
ELC-001
ELC-100
ELC-201
ELC-301
ELC-401
Patents
Pipeline
Pipeline
Clinical trials
Investors
Press Releases
Corporate Governance
the Share
Financial Reports
Financial Calendar
Events
Planned IPO
News
News
Press Releases
Events
Contact
en
/
sv
Management
Jamal El-Mosleh
CEO since 2020 and co-founder
Ingvar Karlsson
Chief Financial Officer since 2021
Magnus Essand
Chief Scientific Officer since 2020 and co-founder
Di Yu
Head of Translational Research and Technical Operations since 2020 and co-founder
